I. Dogan Et Al. , "Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl, pp.14002, 2022
Dogan, I. Et Al. 2022. Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl , 14002.
Dogan, I., Yirgin, I. K., Ozkurt, S., Ibıs, K., Vatansever, S., Saip, P., ... Aydiner, A.(2022). Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl, 14002.
Dogan, Izzet Et Al. "Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl, 14002, 2022
Dogan, Izzet Et Al. "Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl, pp.14002, 2022
Dogan, I. Et Al. (2022) . "Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16_suppl, p.14002.
@article{article, author={Izzet Dogan Et Al. }, title={Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022, pages={14002} }